|
Baseline demographic and clinical characteristics of participants and demographic characteristics of carers, by follow-up group |
|||
| PARTICIPANTS |
|||
|
|
|||
| Characteristic |
Minimal group (n = 88) |
Intensive group (n = 88) |
Total sample (n = 176) |
|
|
|||
| Mean age* |
79.2 (6.8) |
79.7 (8.4) |
79.5 (7.6) |
| Females, Males†† |
55, 33 (62.5%) |
52, 36 (59.1%) |
107, 69 (60.8%) |
| Ethnicity†† |
White: 83 (94.3%) Mixed: 1 (1.1%) Indian: 2 (2.3%) Black: 2 (2.3%) |
White: 84 (95.5%) Indian: 1 (1.1%) Black: 3 (3.4%) |
White: 167 (94.9%) Mixed: 1 (0.6%) Asian or Asian British: 3 (1.7%) Black or Black British: 3 (3.4%) |
| Median years of education† |
10.0 (9.0, 14.0) |
10.0 (9.0, 13.1) |
10.0 (9.0, 13.3) |
| Number with Alzheimer's disease, vascular dementia diagnosis†† |
71, 17 (80.7%) |
77, 11 (87.5%) |
148, 28 (84.1%) |
| Evidence of vascular pathology†† |
40 (45.5%) |
46 (52.3%) |
86 (48.9%) |
| Median MMSE score† |
22.0 (15.0, 26.0) |
23.0 (13.9, 26.0) |
22.0 (15.0, 26.0) |
| Mean ADAS-Cog score* |
23.2 (10.2) |
22.3 (8.9) |
22.7 (9.6) |
| Median carer-reported duration of dementia in years† |
3.0 (1.0, 8.1) |
3.0 (1.3, 8.0) |
3.0 (1.0, 8.0) |
| AChI use†† |
28 (31.8%) |
30 (34.1%) |
58 (33.0%) |
|
|
|||
| CARERS§ |
|||
|
|
|||
| Characteristic |
Minimal group (n = 88) |
Intensive group (n = 88) |
Total sample (n = 176) |
|
|
|||
| Mean age* |
63.1 (14.4) |
65.2 (12.9) |
64.1 (13.7) |
| Females, Males†† |
77, 11 (87.5%) |
75, 13 (85.2%) |
152, 24 (86.4%) |
| Number who are the partner of the participant†† |
45 (51.1%) |
48 (54.5%) |
93 (52.8%) |
| Number who live-in†† |
56 (63.6%) |
59 (67.0%) |
115 (65.3%) |
| Number who are the informal (unpaid) carer†† |
83 (94.3%) |
86 (97.7%) |
169 (96.0%) |
|
* Mean scores are reported with standard deviations. † Median scores are reported with 10th & 90th percentiles. †† Numbers reported with percentage of group (e.g. Ginkgo group); or percentage of females or AD sufferers respectively. § Two participants study carers changed during follow-up. Data is presented for the carer at the end of follow-up. | |||
McCarney et al. BMC Medical Research Methodology 2007 7:30 doi:10.1186/1471-2288-7-30 |
|||